Previous 10 | Next 10 |
2024-01-02 10:00:00 ET Summary United Therapeutics Corporation calls itself a "Public Benefit" company. The reality, it is a cynical monopolist about to lose its monopoly. If patent trolling fails, their premium to the entrant could collapse. Disclaimer . ...
MORRISVILLE, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, beginning at approxim...
2023-12-28 16:42:07 ET More on Liquidia Liquidia jumps on win in patent case against United Therapeutics (update) Liquidia prices equity offering For further details see: Liquidia files for a $200M mixed securities shelf
2023-12-21 08:00:00 ET Summary The U.S. Court declares United Therapeutics' PAH treatment patent unpatentable, favoring Liquidia in the market. Liquidia's modest revenue increase and high R&D and G&A expenses lead to a wider net loss. Liquidia has strong short-term liq...
Liquidia will pursue final FDA approval for YUTREPIA™ (treprostinil) inhalation Liquidia will immediately request that District Court set aside injunction tied to ‘793 patent MORRISVILLE, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia...
2023-12-20 13:13:03 ET Gainers: Polished.com ( POL ) +590% . ParaZero Technologies Ltd ( PRZO ) +75% . Liquidia Corp ( LQDA ) +37% . Ebang International Holdings ( EBON ) +35% . ECARX Holdings ( ECX ) +36% . Mawson Infrastruc...
Liquidia Corporation (NASDAQ: LQDA) is one of today's top gainers. The company's shares have moved 0.48% on the day to $6.23. Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product...
2023-12-20 12:00:32 ET Summary Liquidia Corporation is worth at least $15 in a win. Roivant Sciences is worth at least $12 per share. Burford Capital Limited is worth at least $20 per share. Value & Event Driven Investing I recently spoke for a half an hour a...
2023-12-20 09:54:22 ET More on Liquidia Liquidia Corporation (LQDA) Q3 2023 Earnings Call Transcript Liquidia prices equity offering Liquidia gains as court sets December date for hearing in patent dispute Seeking Alpha’s Quant Rating on Liquidia ...
2023-12-19 06:56:37 ET More on Liquidia Liquidia prices equity offering Liquidia gains as court sets December date for hearing in patent dispute For further details see: Liquidia director buys stock worth $2M
News, Short Squeeze, Breakout and More Instantly...
Liquidia Technologies Inc. Company Name:
LQDA Stock Symbol:
NASDAQ Market:
Liquidia Technologies Inc. Website:
2024-07-12 22:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 17:15:02 ET Oppenheimer analyst issues PERFORM recommendation for LQDA on June 24, 2024 04:14PM ET. LQDA was trading at $12.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 4 - Buy recommendat...
Liquidia to feature two live posters sessions and five encore presentations covering its investigational products, YUTREPIA™ (treprostinil) inhalation powder and L606 (liposomal treprostinil) inhalation suspension MORRISVILLE, N.C., June 18, 2024 (GLOBE NEWSWIRE) -- Liqui...